CAPS To Showcase Its Cardioplegia Portfolio at the 35th Annual Cardiothoracic Surgery Symposium (CREF)
Knowledgeable Experts to Speak at Luncheon
IRVINE, CA – February 9, 2015 – Central Admixture Pharmacy Services, Inc. (CAPS®), announced today that it will showcase its Cardioplegia portfolio of compounded sterile preparations at the CREF 2015 in San Diego, CA, February 11-14, at booth #114.
CAPS will also host a luncheon on Friday, February 13 at the Hilton Bayfront Hotel, Indigo room #204 at 1:00 p.m. entitled, “The Drug Quality and Security Act (DQSA) and the Impact on Cardioplegia,” with speakers Thomas (Tom) Muziani, PA CP, Author of the “Utah Protocol,” and CAPS leadership team members, Mike Koch, R.Ph., MBA, and Todd Jones, RN. This lecture will focus on questions surrounding the new DQSA and its impact on Cardioplegia.
CAPS has two locations registered as Outsourcing Facilities under section 503B of the Drug Quality and Security Act to address customer anticipatory compounding needs. CAPS also offers 23 503A regional pharmacies for customized, patient-specific parenteral nutrition (PN), chemotherapy and hydration.
CAPS® is the nation's largest network of outsourcing admixture pharmacies. CAPS, a pioneer in the outsourcing of compounded sterile preparations was founded in 1991, delivers high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities across the nation. State-licensed and FDA-registered, CAPS pharmacies operate 365 days a year to dispense labeled, patient-specific and anticipatory IV prescriptions. To learn more about CAPS, visit www.CAPSpharmacy.com.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.